{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:35Z","timestamp":1793694635149,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2025ZZBS15"],"award-info":[{"award-number":["2025ZZBS15"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["PY2023023"],"award-info":[{"award-number":["PY2023023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574644"],"award-info":[{"award-number":["82574644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503571"],"award-info":[{"award-number":["82503571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0552400"],"award-info":[{"award-number":["2025ZD0552400"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0552410"],"award-info":[{"award-number":["2025ZD0552410"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LKLZ26H200002"],"award-info":[{"award-number":["LKLZ26H200002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.108459","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:59:19Z","timestamp":1789502359000},"page":"108459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibiting calreticulin palmitoylation enhances the efficacy of elesclomol-CuCl2 on oxaliplatin-triggered immunogenic cell death in pancreatic cancer"],"prefix":"10.1016","volume":"233","author":[{"given":"Zhimiao","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashuo","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-1992","authenticated-orcid":false,"given":"Yuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2026.108459_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10485","key":"10.1016\/j.phrs.2026.108459_bib2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phrs.2026.108459_bib3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.phrs.2026.108459_bib4","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic strategies in pancreatic cancer: making cold tumors hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108459_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41571-025-01077-z","article-title":"The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities","volume":"22","author":"Kung","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13046-023-02831-w","article-title":"Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity","volume":"42","author":"Okabe","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6703","key":"10.1016\/j.phrs.2026.108459_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh4567","article-title":"Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer","volume":"384","author":"Mahadevan","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-019-0817-3","article-title":"Delivery strategies of cancer immunotherapy: recent advances and future perspectives","volume":"12","author":"Zhao","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"7971","key":"10.1016\/j.phrs.2026.108459_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12943-023-01894-9","article-title":"Outsmarting trogocytosis to boost CAR NK\/T cell therapy","volume":"22","author":"Ramezani","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2026.108459_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejca.2022.03.015","article-title":"Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: a phase I study","volume":"169","author":"Lau","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2026.108459_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006650","article-title":"Immune stimulating antibody-photosensitizer conjugates via fc-mediated dendritic cell phagocytosis and phototriggered immunogenic cell death for KRAS-mutated pancreatic cancer treatment","volume":"17","author":"Kim","year":"2021","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.phrs.2026.108459_bib13","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1021\/acsnano.2c06300","article-title":"Nanocarrier co-formulation for delivery of a TLR7 agonist plus an immunogenic cell death stimulus triggers effective pancreatic cancer chemo-immunotherapy","volume":"16","author":"Luo","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.phrs.2026.108459_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406837","article-title":"Harnessing the engineered probiotic-nanosystem to remodulate tumor extracellular matrix and regulate tumor-colonizing bacteria for improving pancreatic cancer chemo-immunotherapy","volume":"21","author":"Yao","year":"2025","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.phrs.2026.108459_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002147","article-title":"Combination chemo-immunotherapy for pancreatic cancer using the immunogenic effects of an irinotecan silicasome nanocarrier plus anti-PD-1","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"issue":"20","key":"10.1016\/j.phrs.2026.108459_bib16","article-title":"Situ vaccination with mitochondria-targeting immunogenic death inducer elicits CD8(+) T cell-dependent antitumor immunity to boost tumor immunotherapy","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"5","key":"10.1016\/j.phrs.2026.108459_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300354","article-title":"Advances in immunogenic cell death for cancer immunotherapy","volume":"7","author":"Ding","year":"2023","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","article-title":"Immunogenic cell death in cancer: concept and therapeutic implications","volume":"21","author":"Galluzzi","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/acsnano.4c10119","article-title":"Dual-enzyme-instructed peptide self-assembly to boost immunogenic cell death by coordinating intracellular calcium overload and chemotherapy","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"issue":"42","key":"10.1016\/j.phrs.2026.108459_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310774","article-title":"Multitargeting prodrugs that release oxaliplatin, doxorubicin and gemcitabine are potent inhibitors of tumor growth and effective inducers of immunogenic cell death","volume":"62","author":"Sarkar","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"14","key":"10.1016\/j.phrs.2026.108459_bib21","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1111\/febs.70102","article-title":"Oxaliplatin accelerates immunogenic cell death by activating the cGAS\/STING\/TBK1\/IRF5 pathway in gastric cancer","volume":"292","author":"Zhao","year":"2025","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.phrs.2026.108459_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.14740\/wjon1768","article-title":"Sphingosine-1-phosphate inhibition increases endoplasmic reticulum stress to enhance oxaliplatin sensitivity in pancreatic cancer","volume":"15","author":"Gao","year":"2024","journal-title":"World J. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2026.108459_bib24","first-page":"200","article-title":"Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer","volume":"30","author":"Duo","year":"2023","journal-title":"Bioact. Mater."},{"issue":"22","key":"10.1016\/j.phrs.2026.108459_bib25","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with alphaPD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"issue":"6586","key":"10.1016\/j.phrs.2026.108459_bib26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.phrs.2026.108459_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202417676","article-title":"Silk fibroin nanoparticles for enhanced cuproptosis and immunotherapy in pancreatic cancer treatment","volume":"12","author":"Gao","year":"2025","journal-title":"Adv. Sci."},{"issue":"51","key":"10.1016\/j.phrs.2026.108459_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3750","article-title":"Comprehensive analysis of spatial architecture in primary liver cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.phrs.2026.108459_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/TP.0000000000004317","article-title":"The novel MyD88 inhibitor TJ-M2010-5 protects against hepatic ischemia-reperfusion injury by suppressing pyroptosis in mice","volume":"107","author":"Zou","year":"2023","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.phrs.2026.108459_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.phrs.2026.108459_bib32","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.7150\/thno.57220","article-title":"Heterogeneity of cell composition and origin identified by single-cell transcriptomics in renal cysts of patients with autosomal dominant polycystic kidney disease","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.phrs.2026.108459_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309984","article-title":"Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108459_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2421028","article-title":"Cytoplasmic HMGB2 orchestrates CALR translocation in the course of immunogenic cell death","volume":"13","author":"Liu","year":"2024","journal-title":"Oncoimmunology"},{"issue":"20","key":"10.1016\/j.phrs.2026.108459_bib36","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the immunogenicity of cell death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12951-025-03874-1","article-title":"Self-activated prodrug nanocomposites reprogramming lactic acid metabolism to initiate acidosis-endoplasmic reticulum stress cascade and potentiate immunogenic cell death for enhanced liver cancer therapy","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2026.108459_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.mcb.2022.01.003","article-title":"Assessment of eIF2alpha phosphorylation during immunogenic cell death","volume":"172","author":"Bezu","year":"2022","journal-title":"Methods Cell. Biol."},{"issue":"17","key":"10.1016\/j.phrs.2026.108459_bib39","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1016\/j.molcel.2024.08.001","article-title":"Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation","volume":"84","author":"Nie","year":"2024","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-025-01738-7","article-title":"Recent advances in S-palmitoylation and its emerging roles in human diseases","volume":"18","author":"Shang","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"32","key":"10.1016\/j.phrs.2026.108459_bib41","article-title":"E3 ubiquitin ligase RNF13 suppresses TLR lysosomal degradation by promoting LAMP-1 proteasomal degradation","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"3","key":"10.1016\/j.phrs.2026.108459_bib42","first-page":"708","article-title":"The value of clinical characteristics and hematological parameters for prognostic assessment of pancreatic cancer patients undergoing radical resection","volume":"55","author":"Zeng","year":"2024","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib43","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41467-025-56493-7","article-title":"A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development","volume":"16","author":"Schneider","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.108459_bib44","article-title":"Palmitic acid and palmitoylation in cancer: understanding, insights, and challenges","volume":"6","author":"Song","year":"2025","journal-title":"Innovaction"},{"issue":"1","key":"10.1016\/j.phrs.2026.108459_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","article-title":"ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis","volume":"23","author":"Mo","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:21:09Z","timestamp":1793694069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S1043661826003749"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108459","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting calreticulin palmitoylation enhances the efficacy of elesclomol-CuCl2 on oxaliplatin-triggered immunogenic cell death in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108459"}}